Drug | Combination drugs | Cancer | Phase | Status | Result | Reference number |
---|---|---|---|---|---|---|
LDE225 | Gemcitabine, Nab-paclitaxel | Locally Advanced or Metastasized Pancreatic Cancer | I/II | Unknown | Â | NCT02358161 |
EN3835 | None | Uterine Leiomyoma | I | Completed | Enough safety and efficacy, and decreased tumor bulk | NCT02889848 |
EN3835 | None | Lipoma | II | Completed | dose escalation study | NCT01613313 |
Losartan | Proton beam radiation, FOLFIRINOX | Locally Advanced Pancreatic Cancer | II | Active, not recruiting | Â | NCT01821729 |
TRC093 | None | Locally Advanced or Metastatic Solid Tumors | I | Completed | Dose escalation study | NCT00492830 |
Halofuginone hydrobromide | None | Human immunodeficiency virus-related Kaposi’s sarcoma | II | Completed | No clear clinical benefits | NCT00064142 |